IIT Hyderabad professor finds cure for ALS that causes Incurable Paralysis


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ IIT Hyderabad
Researchers at IIT Hyderabad have engineered their way to found a new molecule that can help to treat ALS - a neurogenerative disorder.

ALS -- a neurogenerative disorder that severely impacts the voluntary movement of muscles causes paralysis-like symptoms, even death is a very disorder that affects every two people in 100,000 people. World-renowned physicist Stephen Hawking is the most profound example who suffered from ALS.

Now, researchers at IIT Hyderabad have engineered their way to found a new molecule that can help to treat ALS.

Basant Kumar Patel, Associate Pro resefessor, Department of Biotechnology at IIT Hyderabad reveals that one of the primary causes of ALS is the alterations in the genes that code for a critical protein called TDP-43. The alteration of the gene modifies the protein that results in its liquid-liquid phase separation. This phase separation, sequentially, causes the proteins to be deposited on nerve cells, resulting in neurodegeneration.”

In 2016, the research found a molecule named ‘AIM4’ that responded in a more positively in prevention of abnormal aggregation of TFP-43 in vitro ALS disease model systems.

Patel further reveals that they have shown that AIM4 prevents liquid-liquid phase separation of the modified protein, TDP-43-A315T and, in turn, AIM4 averts aggregation of the protein and may potentially foils the deposition on neurons.

AIM$’s ability is tested to prevent protein phase separation with an antihistamine—Dimebon -- that was studied earlier for curing neurogenerative disorders by pharmaceutical companies in the US but failed in clinical trials.

Looking at binding energy calculations of AIM4, it reveals a promising bond between AIM and mutant protein, which is energetically favourable. It is supposed that the drug promising for treatment of ALS in the near future.

Tags : #Iithyderabad #Neurogenerativedisorder #Department #Biotechnology #Incurableparalysis #Medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026